JX 06
Modify Date: 2025-08-25 08:05:56
JX 06 structure
|
Common Name | JX 06 | ||
|---|---|---|---|---|
| CAS Number | 729-46-4 | Molecular Weight | 324.50600 | |
| Density | 1.463g/cm3 | Boiling Point | 466.3ºC at 760 mmHg | |
| Molecular Formula | C10H16N2O2S4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 235.8ºC | |
Use of JX 06JX06 is a potent, selective and covalent inhibitor of PDK. JX06 inhibits PDK1, PDK2 and PDK3 with the IC50s of 49 nM, 101 nM, and 313 nM, respectively. JX06 inhibits PDK1 activity via covalently binding to a cysteine residue in an irreversible manner. JX06 shows significant antitumor activity[1]. |
| Name | morpholine-4-carbothioylsulfanyl morpholine-4-carbodithioate |
|---|---|
| Synonym | More Synonyms |
| Description | JX06 is a potent, selective and covalent inhibitor of PDK. JX06 inhibits PDK1, PDK2 and PDK3 with the IC50s of 49 nM, 101 nM, and 313 nM, respectively. JX06 inhibits PDK1 activity via covalently binding to a cysteine residue in an irreversible manner. JX06 shows significant antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 49 nM (PDK1), 101 nM (PDK2), 313 nM (PDK3)[1] |
| In Vitro | JX06 barely shows inhibitory activity against PDK4 at a concentration of 10 μM[1]. JX06 (1-10 μM; 48 hours) induces cell apoptosis in cancer cells with high ECAR/OCR[1]. JX06 (0-0.6 μM; 72 hours) dose-dependently suppresses the growth of A549 cells[1]. JX06 (0.1-10 μM; 6-24 hours) inhibits PDHA1 phosphorylation in A549 cells in a time- and dose-dependent manner[1]. JX06 (1-10 μM) increases glucose uptake and intracellular ATP level and reduces aerobic glycolysis determined by the lactate production in A549 cells[1]. JX06 (1-10 μM; 24 hours) induces ROS generation in cancer cells with high extracellular acidification rate (ECAR)/ oxygen consumption rate (OCR) [1]. Apoptosis Analysis[1] Cell Line: A549, EBC-1, HT-29 and H460 cells Concentration: 0, 1, 3, 10 μM Incubation Time: 48 hours Result: Induces cell apoptosis in A549 and EBC-1 cells. Cell Viability Assay[1] Cell Line: A549 cells Concentration: 0, 0.2, 0.4, 0.6 μM Incubation Time: 72 hours Result: Inhibits the viability of A549 cells in a dose dependent manner. Western Blot Analysis[1] Cell Line: A549 cells Concentration: 0, 0.1, 0.3, 1, 3, 10 μM Incubation Time: 0, 6, 12, 24 hours Result: Decreased PDHA1 phosphorylation at both serine 293 and serine 232 (S293 and S232) in a time- and dose-dependent manner. |
| In Vivo | JX06 (40-80 mg/kg; i.p. for 21 days) inhibits tumor growth in vivo[1]. Animal Model: A549 subcutaneous xenograft mice[1] Dosage: 40, 80 mg/kg Administration: I.p. injections for 21 days Result: Reduced tumor weights and 67.5% tumor volume at the dose of 80 mg/kg compared with the vehicle control. Well tolerated at the administration dose. |
| References |
| Density | 1.463g/cm3 |
|---|---|
| Boiling Point | 466.3ºC at 760 mmHg |
| Molecular Formula | C10H16N2O2S4 |
| Molecular Weight | 324.50600 |
| Flash Point | 235.8ºC |
| Exact Mass | 324.00900 |
| PSA | 139.72000 |
| LogP | 1.47780 |
| Index of Refraction | 1.69 |
| InChIKey | KKVYOWPPMNSLCP-UHFFFAOYSA-N |
| SMILES | S=C(SSC(=S)N1CCOCC1)N1CCOCC1 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xn |
|---|
|
Name: Inhibition of PDK4 (unknown origin) at 10 uM using full length His6-tagged PDHA1 as s...
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial
External Id: CHEMBL4009666
|
|
Name: Ratio of Kinact to Ki for PDK3 (unknown origin)
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial
External Id: CHEMBL4009664
|
|
Name: QFRET-based biochemical primary high throughput screening assay to identify exosite i...
Source: The Scripps Research Institute Molecular Screening Center
Target: disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id: ADAM17_INH_QFRET_1536_1X%INH PRUN
|
|
Name: Inhibition of full length His6-tagged PDK1 (unknown origin) expressed in Escherichia ...
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial
External Id: CHEMBL4009665
|
|
Name: Inhibition of PDK3 (unknown origin) assessed as inactivation rate using full length H...
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial
External Id: CHEMBL4009663
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Inhibition of PDK2 (unknown origin) assessed as inactivation rate using full length H...
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial
External Id: CHEMBL4009660
|
|
Name: Ratio of Kinact to Ki for PDK2 (unknown origin)
Source: ChEMBL
Target: [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial
External Id: CHEMBL4009661
|
|
Name: Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay
Source: ChEMBL
Target: A549
External Id: CHEMBL4009672
|
|
Name: Antiproliferative activity against human Kelly cells after 72 hrs by CCK8 assay
Source: ChEMBL
Target: N/A
External Id: CHEMBL4009673
|
Total 110, Current Page 1 of 11
1
2
3
4
5
| DISULFIDE,BIS(MORPHOLINOTHIOCARBONYL) |
| Dimorpholinothiuramdisulfid |
| Disulfide,bis(4-morpholinylthioxomethyl) |
| Bis(morpholinothiocarbonyl) disulfide |
| Morpholine,4,4'-(dithiodicarbonothioyl)bis |
| Dimorpholinethiuram disulfide |
| Bis(4-morpholinothiocarbonyl) disulfide |
| N,N'-morpholinothiuram disulfide |
| 4-Morpholinethiocarbonyl disulfide |
| bis(morpholinothiocarbonyl) disulphide |
| 4,4'-(Dithiodicarbonothioyl)dimorpholine |